We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » British Drugmakers Abandon Challenge to New Cost-effectiveness Rules
British Drugmakers Abandon Challenge to New Cost-effectiveness Rules
The trade association of the British drug industry dropped its legal challenge to new guidelines from national regulators that subject higher-priced drugs to an extra review under England’s single-payer National Health Service.